As if the standard Berserker wasn't enough for our troops to deal with, this particular specimen has been substantially modified with some form of auxiliary injection system circulating fluids throughout its body. I believe it may be possible to modify these systems for use in an armor suit of our own, but the fabrication process could a challenge.
The most dangerous of my three test subjects, the Berserker Queen also represents the greatest leap towards the boundaries of what could be considered reasonable and ethical Research. Even in wartime, I must consider the fact that by providing an already unstable alien being with equipment that may further its own capabilities, I risk crossing a line that can never be uncrossed.
Despite a thorough examination of the modified Berserker variant known as subject "Beta," I've yet to uncover any meaningful justification for the enhanced equipment provided by Dr. Vahlen to the creature as it relates to her own research. Let me be clear, I fully understand the creature's enhanced endocrine system requires the addition of this supplementary transport and filtering mechanism to maintain hormonal equilibrium. As well, I admit it is a reasonably elegant solution to an otherwise daunting question.
What I cannot understand is, why it was necessary for Dr. Vahlen to take this relative certainty beyond the theoretical stage. There was no need for a "proof of concept" here, the end result was no doubt as clear to her then as it is to me now. I firmly believe she made a conscious decision to see her work through to the end, knowing full well the risks not only to herself but to everyone else who might encounter subject Beta in the future. I am thankful we found the creature when we did, and that our forces were capable of neutralizing such a formidable enemy.
The senior staff has agreed that the remains of Beta would best be utilized as part of an enhanced armor suit, although the actual conversion process sounds like something that would have been better handled by Dr. Vahlen herself. R. Tygan.